Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation
- 1 April 1995
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 71 (4), 697-704
- https://doi.org/10.1038/bjc.1995.137
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistanceInternational Journal of Cancer, 1994
- The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF‐7 breast carcinoma cellsInternational Journal of Cancer, 1994
- Phase I Study of Bryostatin 1: Assessment of Interleukin 6 and Tumor Necrosis Factor Induction In VivoJNCI Journal of the National Cancer Institute, 1993
- Modulation by staurosporine of phorbol‐ester‐induced effects on growth and protein kinase C localization in a549 human lung‐carcinoma cellsInternational Journal of Cancer, 1992
- Staurosporine is a potent inhibitor of p34cdc2 and p34cdc2-like kinasesBiochemical and Biophysical Research Communications, 1992
- 2,6-Diamino-N-([1-(1-oxotridecyl)-2-piperidinyl]methyl)hexanamide (NPC 15437): A selective inhibitor of protein kinase CInflammation Research, 1991
- Staurosporine, a potent inhibitor of C-kinase, enhances drug accumulation in multidrug-resistant cellsBiochemical and Biophysical Research Communications, 1990
- Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase CBiochemical and Biophysical Research Communications, 1989
- Effects of activators of protein kinase C, including bryostatins 1 and 2, on the growth of A549 human lung carcinoma cellsInternational Journal of Cancer, 1989
- Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinaseBiochemical and Biophysical Research Communications, 1986